Puma Biotechnology Inc
PBYI
NASDAQ
Biotechnology
$8.83
USD
+0.12 (+1.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $454.88M
Volume 232.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MPLT | MapLight Therapeutics Inc | $519.09M | - | - | - | |
OVID | Ovid Therapeutics Inc | $518.86M | - | +1199.6% | - | |
KYTX | Kyverna Therapeutics Inc | $479.67M | - | - | - | |
QTTB | Q32 Bio Inc | $468.57M | 15.71 | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - | |
LRMR | Larimar Therapeutics Inc | $445.14M | - | - | - | |
RZLT | Rezolute Inc | $442.94M | - | - | - | |
CABA | Cabaletta Bio Inc | $442.69M | - | - | - | |
PRLD | Prelude Therapeutics Inc | $431.68M | - | - | - |
Top Peer by Growth
Ovid Therapeutics Inc
+1199.6% YoY Revenue
Lowest P/E Ratio
Q32 Bio Inc
15.71x P/E
Best 1-Year Return
Q32 Bio Inc
+749.2% Return